Chugai Pharma Germany company information, Employees & Contact Information

Roche's Chugai strikes $200M M&A deal to take over IgAN asset in several Asian countries Fierce Pharma

Renalys Pharma to be Acquired by Chugai Pharmaceutical citybiz

Roche axes 4 Chugai solid tumor assets in early-phase clear-out Fierce Biotech

Rani Therapeutics signs up to $1.09 billion licensing deal with Japan's Chugai Pharma Reuters

Chugai 100th Anniversary: A century of innovation to benefit patients Roche

Chugai and Gero Enter into Joint Research and License GlobeNewswire

CHUGAI INNOVATION DAY 2024 Report—More Than 3,000 in Attendance chugai-pharm.co.jp

Roche’s Chugai Breaks Into Aging via Potential $1B+ Deal With AI Outfit Gero BioSpace

Chugai wins new approval in Japan for Vabysmo The Pharma Letter

Chugai stock drops the most since 1977 on disappointing obesity drug data The Japan Times

Chugai Pharmaceuticals’ AI Strategy: Analysis of Dominance in Pharma AI Klover.ai

Roche’s Chugai inks $250M Gero deal to access age-related disease targets Fierce Biotech

Von Willebrand disease: Star Therapeutics, Chugai and Band Therapeutics are breaking new ground Labiotech.eu

9 out of 10 patients with CINV report an impact on their daily life – Chugai Pharma Europe Oncodaily

Chugai buys a kidney biotech; ICER targets rising launch prices BioPharma Dive

RANI: Chugai Deal Announced Yahoo Finance

Apr 25,2022 | Organizational and Personnel Changes | News | CHUGAI PHARMACEUTICAL CO., LTD. chugai-pharm.co.jp

AstraZeneca pays $775M to settle patent dispute over Alexion drug BioPharma Dive

Construction of Chugai’s New Research Center “Chugai Life Science Park Yokohama” Reached Completion chugai-pharm.co.jp

Greater Efficiency in Bioprocess Development. Digital Transformations in Pharmaceuticals chugai-pharm.co.jp

Chugai and Gero link on antibody drugs for age-related conditions Pharmaceutical Technology

Chugai Moves Device Management to the Cloud with Intune & Entra ID enabling a Hybrid Work Environment Microsoft

Strategic Alliance with Roche | Our Strategy | About Chugai | CHUGAI PHARMACEUTICAL CO., LTD. chugai-pharm.co.jp

The Bio Lab’s Development of the Next Generation of Scientists | Story | CHUGAI PHARMACEUTICAL CO., LTD. chugai-pharm.co.jp

Rani Therapeutics Announces Research Agreement with Chugai Yahoo Finance

NEC and Chugai Pharmaceutical use AI to potentially enhance cancer treatment: Press Releases NEC Global

Roche's Chugai places $250M wager on Gero's AI to crack age-related disease FirstWord Pharma

Chugai Pharmaceutical (TSE:4519): Is the Quiet Share Momentum Reflecting True Value? Yahoo Finance

Chugai Life Science Park Yokohama certified as a Natural Symbiosis Site by the Ministry of the Environment chugai-pharm.co.jp

How Positive Phase 3 Results for Orforglipron at Chugai Pharmaceutical (TSE:4519) Changed Its Investment Story Yahoo Finance

Chugai and Biofourmis Enter into New Partnership Focused on Data-Driven Virtual Care for Endometriosis-Related Pain PR Newswire

Chugai Pharmaceutical To Buy Renalys Pharma, Expanding Kidney Disease Portfolio Across Asia Pulse 2.0

Halozyme Therapeutics, Inc. and Chugai Pharmaceutical Enter Global Collaboration and License Agreement for ENHANZE® Technology PR Newswire

Roche's Chugai reports first Phase III Vabysmo data for rare retinal condition FirstWord Pharma

Feature: 2. Working to make Chugai synonymous with oncology chugai-pharm.co.jp

Roche's Chugai pays Halozyme $25M to access subcutaneous delivery tech Fierce Pharma

Chugai spikes after Eli Lilly trial win for obesity pill Seeking Alpha

Chugai licenses out early-stage cancer candidate to Menarini Fierce Biotech

Biofourmis, Chugai to develop wearable for digitally measuring endometriosis pain Fierce Biotech

Genentech and Chugai's Hemlibra Receives FDA Approval for Hemophilia A Without Inhibitors drugdiscoverytrends.com

Verastem pens KRAS-focused drug licensing deal with Chugai Fierce Biotech

Weight-loss pill orforglipron shines in study, boosting Lilly and Chugai The Japan Times

Eli Lilly nets an early-stage GLP-1 diabetes drug from Chugai for $50M Fierce Biotech

RFK Jr. could spell trouble for obesity drug from Japan's Chugai Nikkei Asia

Chugai bags phase II-based approval in Japan for three-drug DLBCL treatment BioWorld MedTech

Chugai launches NMOSD treatment Enspryng in Japan BioWorld MedTech

Chugai Pharmaceutical Opens a North American Hub in Berkeley Heights New Jersey Business Magazine

Nobel in medicine shows fruits of Japan's Chugai backing basic research Nikkei Asia

Oral obesity treatment trials on track, head of Japan's Chugai says Nikkei Asia

Japan needs 'drug discovery ecosystem,' says Chugai head Nikkei Asia

Chugai Pharmaceutical Co. Singapore Economic Development Board (EDB)

Mover & Shaker of the month: Troy Robinson Pf Media

Chugai appoints Ruth Currie as MD of its UK business PMLiVE

Chugai Pharmaceutical Bulk Antibody Pharmaceutical Technology

Chugai Pharma to inject $220m into Singapore bio drug lab Nikkei Asia

Chugai Releases Disease Awareness Anime about Rheumatoid Arthritis in Multiple Languages Emphasizing Importance of Early Detection/Treatment and Care by Specialists ANSA